Zolboo Gemgui, FNP-C, MSN, RN

Zolboo Gemgui practices at Mountain Manor Senior Residence in Carmichael, California.

Zolboo Gemgui's NPI, 1285344788, was assigned on November 25, 2022. Zolboo Gemgui holds California license 95021092.

Zolboo Gemgui's primary practice is Mountain Manor Senior Residence, at 6101 Fair Oaks Blvd, Carmichael, CA 95608 in Sacramento County. The practice phone is (916) 488-7211.

Zolboo Gemgui's primary practice is Mountain Manor Senior Residence in Carmichael, California. The medical group on file is PALTM Medical Corporation. Dmand AI also links Zolboo Gemgui to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zolboo Gemgui practices. Vendor and product names are available with a free account.

Family is Zolboo Gemgui's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Zolboo Gemgui is licensed in California.

Dmand AI lists anxiety, arthritis, asthma, chronic diabetes, chronic kidney disease, chronic nasal allergies, chronic obstructive pulmonary disease (COPD) and enlarged prostate among the conditions Zolboo Gemgui treats.

CMS data shows 1,082 Medicare services from Zolboo Gemgui across 3 procedure codes in 2024, for 223 Medicare patients. Medicare paid $76,441 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 223 Medicare patients who saw Zolboo Gemgui in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zolboo Gemgui's median patient age at 59, with 73% women.

In 2024, Zolboo Gemgui wrote 1,110 Medicare Part D claims for 171 patients. 89% of them were for generic drugs. CMS names the drug for 673 of them, across 33 drugs with 11 or more claims each, at $19,997 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Zolboo Gemgui for performance year 2024, reported as part of a group.